Trial intelligence / Profile preview

Adjuvant Atorvastatin in Locally Advanced Prostate Cancer

NCT01759836Phase 2Completed

Sponsor
Asan Medical Center
Start
Oct 2012
Primary completion
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of atorvastatin in prostate cancer (PCa), sponsored by Asan Medical Center. Started Oct 2012; status: completed.

02

Drugs

atorvastatin
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT01759836.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01759836.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call